ClinicalTrials.gg
CompletedNCT07870902Updated Oct 13, 2026

Desarda Repair for Inguinal Hernia in Adolescent Males

An observational study in Inguinal Hernia, sponsored by Medical University of Silesia. Completed at 1 site in Poland. Open to male participants aged 11 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Medical University of Silesia · Observational

Updated Oct 13, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
12
Ages
11 Years to 18 Years
Sex
Male
01

Study summary

This retrospective single-centre case series evaluates the feasibility and clinical outcomes of selective open Desarda repair for inguinal hernia in adolescent males treated in a paediatric surgical department. The study focuses on recurrence, postoperative complications, reoperation, persistent groin pain, postoperative length of stay, and follow-up after Desarda repair.

Read the detailed description

The institutional operative database and medical records were reviewed for inguinal hernia surgery performed between January 2016 and 30 May 2026. The registered case series comprises adolescent males aged 11 to 18 years who underwent elective open Desarda repair during this period. Desarda repair was used selectively when intraoperative assessment showed a well-preserved external oblique aponeurosis suitable for tissue-based posterior wall reconstruction. Patients with markedly thinned, attenuated, or fragmented aponeurosis were considered unsuitable for this technique. The study is descriptive and retrospective, with no formal hypothesis testing or comparator group within the registered Desarda cohort.

02

Conditions studied

  • Inguinal Hernia

Browse trials for

Keywords

  • adolescent inguinal hernia
  • Desarda repair
  • tissue-based repair
  • posterior wall reconstruction
  • paediatric surgery
  • case series
03

In context

Hernia, Inguinal

561 studies on the registry are indexed under Hernia, Inguinal; 76 are open to participants now.

This study's enrollment of 12 is below the median of 150 across 137 observational studies indexed under Hernia, Inguinal.

Browse Hernia, Inguinal studies →

Lead sponsor

Medical University of Silesia is the lead sponsor of 113 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 18 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Male adolescent patients treated at a single tertiary paediatric surgical centre in Zabrze, Poland, who underwent elective open Desarda repair for inguinal hernia.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male patients aged 11 to 18 years.
  • Elective open Desarda repair for inguinal hernia performed at the study centre during the study period.

Exclusion criteria

Exclusion Criteria:

  • Patients outside the specified age range.
  • Female patients.
  • Patients treated with an inguinal hernia repair technique other than Desarda repair.
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
12 participants (actual)
Patient registry
No

Groups and cohorts

  • Desarda repair cohort

    Twelve adolescent male patients who underwent 13 elective open Desarda repairs. One patient underwent staged bilateral repair during separate admissions.

    Procedure: Open Desarda inguinal hernia repair

Interventions

  • ProcedureOpen Desarda inguinal hernia repair

    Open non-mesh posterior wall reconstruction using an undetached strip of the external oblique aponeurosis according to the principles of the Desarda technique.

    Also known as: Desarda repair

06

What researchers measure

Primary outcomes

  1. Number of Desarda repairs with clinically documented ipsilateral inguinal hernia recurrence

    Ipsilateral recurrence was defined as a clinically confirmed inguinal hernia occurring on the same side as the index Desarda repair and documented in the medical record during follow-up. Development of a contralateral inguinal hernia was not considered a recurrence.

    Time frame: From surgery up to 7.5 years after surgery

Secondary outcomes

  1. Number of participants undergoing reoperation after Desarda repair

    Any reoperation related to ipsilateral recurrence or postoperative complications following Desarda repair.

    Time frame: From surgery up to 7.5 years after surgery

  2. Number of participants with persistent groin pain documented in medical records

    Binary outcome (yes/no) based on medical record documentation of pain or discomfort in the operated groin persisting beyond 3 months after surgery. No standardized pain scale was used.

    Time frame: From 3 months after surgery up to 7.5 years after surgery

  3. Number of participants with postoperative complications

    Number of participants with at least one postoperative complication, including wound infection, wound dehiscence, inguinal or scrotal swelling, postoperative hydrocele, scrotal haematoma, sensory disturbance, or unplanned readmission. Complications were assessed throughout the available postoperative follow-up for each participant.

    Time frame: From surgery up to 7.5 years after surgery

  4. Postoperative hospital length of stay in days

    Postoperative hospital stay measured in days.

    Time frame: During the index hospitalization, from surgery to hospital discharge, up to 2 days after surgery

07

Study locations

1 site
  • Department of Children's Developmental Defects Surgery and Traumatology, Medical University of Silesia in Katowice
    Zabrze, Silesian Voivodeship 41-808, Poland
08

References and documents

Individual participant data

Plan to share: No — Individual participant data are not planned for public sharing because the study involves a small paediatric cohort with potentially identifiable clinical information. Anonymised data may be available from the corresponding author upon reasonable request and subject to institutional and ethical approval.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07870902
Responsible party
Michał Pasierbek (Senior Assistant, Paediatric Surgeon., Medical University of Silesia) — Principal investigator
First posted
Oct 13, 2026
Start date
Jun 23, 2016
Primary completion
Feb 12, 2026
Completion
Feb 12, 2026
Last update
Oct 13, 2026

Study contacts

Michał Pasierbek, MD, PhD
principal investigator · Medical University of Silesia in Katowice

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion